Les Funtleyder

Type: Person
Name: Les Funtleyder
First reported 3 hours ago - Updated 3 hours ago - 1 reports

Obamacare Dividends Pile Up for Hospitals as More Patients Pay

July 30 (Bloomberg) -- Even as Obamacare continues to be attacked by Republicans and challenged in court, hospital chains are making more money, more patients using ERs are paying for their care and the country as a whole is enjoying slower growth in ... [Published Washington Post - 3 hours ago]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Video: What's coming in biotech?

"The market is very favorable for biotech these days," says Les Funtleyder, Bluecloud Healthcare, in discussing growth in the space. (CNBC) ... [Published NBCNews.com - Jul 23 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Wall Street wonders what Shire is worth

The share prices of AbbVie ($ABBV) and takeover target Shire ($SHPG) keep drifting downward amid sustained uncertainty over a deal. A couple of healthcare investors we talked to feel the deal is by no means definite--a concern that is also reflected in ... [Published FierceBiotech - Jul 10 2014]
First reported Jul 05 2014 - Updated Jul 05 2014 - 1 reports

AbbVie battle for Shire: why this time it's different

Another US corporate eagle may be succeed where Pfizer failed, swooping on the Jersey-registered drug company Shire Just five weeks after Pfizer walked away from its £70bn attempt to buy AstraZeneca, another American suitor has come knocking on the door ... [Published Telegraph - Jul 05 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 1 reports

Hospitals to Get 2.1% Pay Boost on Medicare Outpatients

The Obama administration proposedraising Medicare payments to hospitals for care they provide onan outpatient basis, part of a trend toward discouragingunnecessary admissions.Payments for outpatient services would be increased 2.1percent under a proposal ... [Published Bloomberg - Jul 03 2014]
First reported Jun 28 2014 - Updated Jun 28 2014 - 1 reports

Another Pfizer bid for AstraZeneca? Investors weigh in

A higher price could get a deal done between Pfizer ($PFE) and AstraZeneca ($AZN) if British regulators play along, but investors aren't convinced that would be a particularly good outcome for either company. The two pharmas aren't far apart on price, ... [Published FierceBiotech - Jun 28 2014]
First reported May 02 2014 - Updated May 02 2014 - 1 reports

Investing in Africa

Steven Adjei, Kwaku Obeng-Appiah and Les Funtleyder outline the healthcare sector in Africa and look at the factors affecting foreign direct investment.Even though Africa boasts a fifth of the world’s population, it only accounts for 3% of the world’s ... [Published Pharmaceutical Executive - May 02 2014]

Quotes

"the market is very favorable for biotech these days" says Les Funtleyder, Bluecloud Healthcare, in discussing growth in the space. (CNBC)
"there is at least more strategic rationale for this deal. shire is offering rare diseases, which are a sweet spot, whereas pfizer was much more obvious that its interest hinged on financial engineering" said Les Funtleyder, consulting partner at health care investor BlueCloud

More Content

All (9) | News (8) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Obamacare Dividends Pile Up for Hospitals as Mo... [Published Washington Post - 3 hours ago]
Video: What's coming in biotech? [Published NBCNews.com - Jul 23 2014]
Wall Street wonders what Shire is worth [Published FierceBiotech - Jul 10 2014]
AbbVie battle for Shire: why this time it's dif... [Published Telegraph - Jul 05 2014]
Hospitals to Get 2.1% Pay Boost on Medicare Out... [Published Bloomberg - Jul 03 2014]
Another Pfizer bid for AstraZeneca? Investors w... [Published FierceBiotech - Jun 28 2014]
Investing in Africa [Published Pharmaceutical Executive - May 02 2014]
Prove It! Top Line Thoughts on Trends That Will... [Published theCSRfeed - Jan 27 2014]
Prove It! Top Line Thoughts on Trends That Will... [Published Pharmaceutical Executive - Jan 10 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Prove It! Top Line Thoughts on Trends That Will... [Published theCSRfeed - Jan 27 2014]
SOURCE: Advanstar DESCRIPTION: Full Article: Click here Ten days in and the New Year already seems old.  Yet members of our Pharm Exec Editorial Advisory Board are still eager to share their top of line predictions on trends that will shape ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.